Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced an update to its Share Trading Policy effective from 26 April 2024, in line with ASX Listing Rule 12.10. The biotech company, known for its development of iNKT cell therapy for treating various cancers, including blood cancers and solid tumours, is also advancing with its CAR19-iNKT cells and CLDN18.2-targeting technology for solid tumour treatment.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
